XP CHEMISTRIES AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.12 SEK | -7.69% |
|
-19.46% | +0.84% |
| 05-17 | XP Chemistries AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 02-22 | XP Chemistries AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
| Sales 2022 | 1.06M 100K 7.87M | Sales 2023 | 664K 63.06K 4.95M | Capitalization | 11.12M 1.06M 82.89M |
|---|---|---|---|---|---|
| Net income 2022 | -7M -665K -52.19M | Net income 2023 | -8M -760K -59.64M | EV / Sales 2022 | 0.87 x |
| Net cash position 2022 | 15.2M 1.44M 113M | Net cash position 2023 | 7.83M 744K 58.35M | EV / Sales 2023 | 4.96 x |
| P/E ratio 2022 |
-1.74
x | P/E ratio 2023 |
-0.46
x | Employees | 2 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 80.21% |
More Fundamentals
* Assessed data
More news
| 1 day | -7.69% | ||
| 1 week | -19.46% | ||
| 1 month | +169.66% | ||
| 3 months | +258.21% | ||
| 6 months | -14.29% | ||
| Current year | +0.84% |
1 week
0.12
0.21
1 month
0.040.21
Current year
0.030.21
1 year
0.030.80
3 years
0.034.50
5 years
0.034.50
10 years
0.034.50
| Managers | Title | Age | Since |
|---|---|---|---|
Erik Nelsson
CEO | Chief Executive Officer | 41 | 31/12/20 |
Anders Frejdh
DFI | Director of Finance/CFO | 50 | 31/12/20 |
Shuang Zheng Lin
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Armando Córdova
FOU | Founder | 54 | 31/12/14 |
Jonas Hafrén
BRD | Director/Board Member | 55 | 31/12/20 |
Samson Afewerki
FOU | Founder | 39 | 31/12/14 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/05/24 | 0.12 | -7.69% | 845,733 |
| 30/05/24 | 0.13 | -7.80% | 677,772 |
| 29/05/24 | 0.141 | -30.88% | 2,879,394 |
| 28/05/24 | 0.204 | -1.92% | 1,369,896 |
| 27/05/24 | 0.208 | +39.60% | 4,098,132 |
Delayed Quote Nasdaq Stockholm, May 31, 2024 at 04:07 pm
More quotes
XP Chemistries AB is a Sweden-based chemical, biological and pharmaceutical manufacturer. The Company has an international patent portfolio covering sustainable nature-inspired technologies optimal combinations of catalytic processes for the production of bio-based chemicals.
Sector
Pharmaceuticals
Calendar
18/08/2024
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +0.84% | 1.06M | |
| +40.73% | 739B | |
| +32.83% | 598B | |
| -6.30% | 353B | |
| +15.15% | 318B | |
| +4.05% | 285B | |
| +15.00% | 240B | |
| -5.52% | 206B | |
| +6.17% | 164B | |
| -0.45% | 162B |
- Stock Market
- Equities
- XPC Stock
